|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
Chief Executive Officer
Executive Director
|
21,833
+28.3%
358.89
US$3,282,802
|
21,833
+28.3%
|
358.89
|
US$3,282,802
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer; Director
Executive Director
|
84,342
78.59
US$4,492,346
|
84,342
|
78.59
|
US$4,492,346
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Director
Non-Executive Director
|
28,358
451.21
US$310,943
|
28,358
|
451.21
|
US$310,943
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer
Executive Director
Large shareholder
|
1,000
-0.3%
0.21
CA$100,000
|
1,000
-0.3%
|
0.21
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Director of Issuer
Non-Executive Director
|
1,000
+0.3%
0.50
CA$100,000
|
1,000
+0.3%
|
0.50
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
1,000
+14.2%
92.00
CA$100,000
|
1,000
+14.2%
|
92.00
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
10% Security Holder of Issuer
Large shareholder
|
1,000
+0.1%
0.34
CA$100,000
|
1,000
+0.1%
|
0.34
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Director of Issuer
Non-Executive Director
|
1,000
+16.1%
26.78
CA$100,000
|
1,000
+16.1%
|
26.78
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
Senior Officer of Issuer
Officer
|
1,000
-70.0%
14.40
CA$100,000
|
1,000
-70.0%
|
14.40
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
Senior Officer of Issuer
Officer
|
1,000
-52.0%
14.41
CA$100,000
|
1,000
-52.0%
|
14.41
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Senior Officer of Issuer
Officer
|
1,000
+0.6%
0.28
CA$100,000
|
1,000
+0.6%
|
0.28
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Senior Officer of Issuer
Officer
|
1,000
+0.0%
2.76
CA$100,000
|
1,000
+0.0%
|
2.76
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
Director of Issuer
Non-Executive Director
|
1,000
-99.0%
0.19
CA$100,000
|
1,000
-99.0%
|
0.19
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
1,000
+0.4%
0.05
CA$100,000
|
1,000
+0.4%
|
0.05
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Director of Issuer
Non-Executive Director
|
1,000
+0.0%
0.09
CA$100,000
|
1,000
+0.0%
|
0.09
|
CA$100,000
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer
Officer
|
60,463
12.58
US$760,625
|
60,463
|
12.58
|
US$760,625
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer
Officer
|
146,874
12.58
US$1,847,670
|
146,874
|
12.58
|
US$1,847,670
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer
Officer
|
132,558
12.58
US$1,667,580
|
132,558
|
12.58
|
US$1,667,580
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer
Officer
|
156,795
12.58
US$1,972,481
|
156,795
|
12.58
|
US$1,972,481
|
|
|
2026-09-04 |
2026-09-04 |
|
B
Purchase
|
Chief Executive Officer
Executive Director
|
13,035
+5.6%
19.15
US$249,620
|
13,035
+5.6%
|
19.15
|
US$249,620
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer; Director
Executive Director
|
440,752
12.58
US$5,544,660
|
440,752
|
12.58
|
US$5,544,660
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
Officer
Officer
|
1,654
22.29
US$36,867
|
1,654
|
22.29
|
US$36,867
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
37,500
516.39
US$19,364,625
|
37,500
|
516.39
|
US$19,364,625
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
1,119
516.39
US$577,840
|
1,119
|
516.39
|
US$577,840
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
504
516.39
US$260,261
|
504
|
516.39
|
US$260,261
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
EVP, General Counsel
Officer
|
1,100
-0.8%
43.67
US$48,039
|
1,100
-0.8%
|
43.67
|
US$48,039
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
EVP, General Counsel
Officer
|
2,154
-1.6%
42.79
US$92,173
|
2,154
-1.6%
|
42.79
|
US$92,173
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
Chief Scientific & Med Officer
Officer
|
2,705
-2.0%
43.66
US$118,105
|
2,705
-2.0%
|
43.66
|
US$118,105
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
Chief Scientific & Med Officer
Officer
|
10,405
-7.1%
42.89
US$446,305
|
10,405
-7.1%
|
42.89
|
US$446,305
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
49,947
516.39
US$25,792,131
|
49,947
|
516.39
|
US$25,792,131
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
Chief Financial Officer
Officer
|
1,175
-0.7%
43.71
US$51,364
|
1,175
-0.7%
|
43.71
|
US$51,364
|
|
|
2026-09-04 |
2026-09-04 |
|
PlS
Planned sale
|
Chief Financial Officer
Officer
|
2,477
-1.5%
42.81
US$106,030
|
2,477
-1.5%
|
42.81
|
US$106,030
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
28,698
516.39
US$14,819,360
|
28,698
|
516.39
|
US$14,819,360
|
|
|
2026-09-04 |
2026-09-04 |
|
PrS
Proposed sale
|
See Remarks
|
54,732
516.39
US$28,263,057
|
54,732
|
516.39
|
US$28,263,057
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
Chief Executive Officer
Executive Director
|
172,706
-39.0%
44.86
US$7,746,728
|
172,706
-39.0%
|
44.86
|
US$7,746,728
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
399
-0.0%
366.56
US$146,256
|
399
-0.0%
|
366.56
|
US$146,256
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
826
-0.1%
365.41
US$301,832
|
826
-0.1%
|
365.41
|
US$301,832
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,329
-0.1%
364.48
US$484,390
|
1,329
-0.1%
|
364.48
|
US$484,390
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,329
-0.1%
364.48
US$484,390
|
1,329
-0.1%
|
364.48
|
US$484,390
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
565
-0.0%
363.34
US$205,287
|
565
-0.0%
|
363.34
|
US$205,287
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
565
-0.0%
363.34
US$205,287
|
565
-0.0%
|
363.34
|
US$205,287
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,992
-0.2%
362.65
US$722,404
|
1,992
-0.2%
|
362.65
|
US$722,404
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,992
-0.2%
362.65
US$722,404
|
1,992
-0.2%
|
362.65
|
US$722,404
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,242
-0.1%
361.61
US$449,120
|
1,242
-0.1%
|
361.61
|
US$449,120
|
|
|
2026-09-04 |
2026-09-04 |
|
S
Sale
|
President, R&D
Executive Director
Large shareholder
|
1,242
-0.1%
361.61
US$449,120
|
1,242
-0.1%
|
361.61
|
US$449,120
|
|